Related Experiment Videos
Plasma membrane shedding and colloid vacuoles in hyperactive human thyroid tissue
Summary
Thyroid-stimulating immunoglobulins (TSI) increase colloid vacuoles in hyperactive thyroid tissue. This membrane material in the follicle lumen may trigger vacuole formation and autoantibody development in Graves' disease.
Area of Science:
- Endocrinology
- Cell Biology
- Immunology
Background:
- Colloid vacuoles are a hallmark of human thyroid gland hyperactivity.
- Understanding the ultrastructural basis of these vacuoles is crucial for thyroid disease research.
- Thyroid-stimulating immunoglobulins (TSI) are implicated in hyperthyroid conditions like Graves' disease.
Purpose of the Study:
- To investigate the ultrastructural appearance of colloid vacuoles in hyperactive human thyroid tissue.
- To determine the origin and composition of intraluminal membrane material associated with these vacuoles.
- To explore the potential role of this material in the pathogenesis of hyperthyroidism and autoimmune thyroid disease.
Main Methods:
- Human thyroid tissue (normal and toxic diffuse goiter) was transplanted into nude mice.
- Transplants and human thyroid tissue from thyrotoxicosis patients were treated with TSI or fixed directly.
- Light and electron microscopy were used to analyze tissue ultrastructure and intraluminal contents.
Main Results:
- TSI administration significantly increased colloid vacuole formation in transplanted thyroid tissue.
- Electron microscopy revealed abundant intraluminal membrane material, associated with colloid vacuoles, in TSI-exposed tissue.
- This membrane material, resembling shed microvilli, showed positive peroxidase activity, suggesting follicular cell origin.
Conclusions:
- Intraluminal membrane material, likely derived from apical plasma membrane shedding, is strongly associated with colloid vacuole formation in hyperactive thyroid tissue.
- The presence of this membrane material may precipitate colloid vacuole formation in hyperthyroidism.
- This intraluminal material could play a role in the immune system's exposure to thyroid microsomal antigen, potentially contributing to autoantibody development in Graves' disease.